1. Home
  2. STTK vs ASYS Comparison

STTK vs ASYS Comparison

Compare STTK & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.01

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$17.60

Market Cap

242.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
ASYS
Founded
2016
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
242.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
ASYS
Price
$4.01
$17.60
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$6.20
N/A
AVG Volume (30 Days)
893.1K
458.9K
Earning Date
11-06-2025
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
$79,364,000.00
Revenue This Year
N/A
$2.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$3.20
52 Week High
$4.89
$18.59

Technical Indicators

Market Signals
Indicator
STTK
ASYS
Relative Strength Index (RSI) 49.25 68.08
Support Level $3.92 $16.36
Resistance Level $4.46 $18.59
Average True Range (ATR) 0.35 1.24
MACD -0.12 0.02
Stochastic Oscillator 20.64 79.96

Price Performance

Historical Comparison
STTK
ASYS

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

Share on Social Networks: